Larry Seidman

467 total citations
14 papers, 347 citations indexed

About

Larry Seidman is a scholar working on Epidemiology, Pathology and Forensic Medicine and Urology. According to data from OpenAlex, Larry Seidman has authored 14 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Pathology and Forensic Medicine and 3 papers in Urology. Recurrent topics in Larry Seidman's work include Reproductive Health and Contraception (3 papers), Urinary Bladder and Prostate Research (3 papers) and Urinary Tract Infections Management (2 papers). Larry Seidman is often cited by papers focused on Reproductive Health and Contraception (3 papers), Urinary Bladder and Prostate Research (3 papers) and Urinary Tract Infections Management (2 papers). Larry Seidman collaborates with scholars based in United States, Israel and Sweden. Larry Seidman's co-authors include Alan Kivitz, William Koltun, Vipul Devas, Ronald Emkey, Kathleen Beusterien, Daiva Masanauskaite, Daniel Lama, Paul Siami, Ginger D. Constantine and James H. Pickar and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Obstetrics and Gynecology and The Journal of Urology.

In The Last Decade

Larry Seidman

14 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry Seidman United States 9 102 95 61 60 58 14 347
Sukanya Chaikittisilpa Thailand 12 138 1.4× 67 0.7× 6 0.1× 112 1.9× 152 2.6× 39 457
Andrea Delbarba Italy 11 42 0.4× 22 0.2× 9 0.1× 11 0.2× 103 1.8× 24 278
Joel Lippman United States 11 12 0.1× 17 0.2× 13 0.2× 81 1.4× 203 3.5× 16 534
George Kaparos Greece 11 21 0.2× 25 0.3× 2 0.0× 53 0.9× 96 1.7× 37 398
Sowmya Krishnan United States 12 7 0.1× 10 0.1× 41 0.7× 22 0.4× 112 1.9× 25 330
Suat Hayri Küçük Türkiye 10 38 0.4× 61 0.6× 2 0.0× 33 0.6× 14 0.2× 26 329
Mervat M. El-Eshmawy Egypt 10 10 0.1× 14 0.1× 3 0.0× 13 0.2× 94 1.6× 30 351
T. B. Paul Geurts Netherlands 11 12 0.1× 8 0.1× 13 0.2× 20 0.3× 251 4.3× 20 442
Yogesh Saxena India 8 40 0.4× 38 0.4× 4 0.1× 4 0.1× 13 0.2× 29 298
Jens Ulrich Hanisch Germany 12 4 0.0× 7 0.1× 63 1.0× 9 0.1× 217 3.7× 18 412

Countries citing papers authored by Larry Seidman

Since Specialization
Citations

This map shows the geographic impact of Larry Seidman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Seidman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Seidman more than expected).

Fields of papers citing papers by Larry Seidman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Seidman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Seidman. The network helps show where Larry Seidman may publish in the future.

Co-authorship network of co-authors of Larry Seidman

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Seidman. A scholar is included among the top collaborators of Larry Seidman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Seidman. Larry Seidman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Millman, Zachary B., Daphne J. Holt, Matcheri S. Keshavan, et al.. (2023). ACNP 62nd Annual Meeting: Poster Abstracts P501 – P753. Neuropsychopharmacology. 48(S1). 355–495. 1 indexed citations
2.
Velthorst, Eva, Carrie E. Bearden, Jean Addington, et al.. (2017). 42. Heterogeneity of Neuropsychological Profiles in the Prodrome to Psychosis: An Examination of the Association Between Cognition and Clinical Outcomes in NAPLS-1. Schizophrenia Bulletin. 43(suppl_1). S23–S24. 1 indexed citations
3.
Seidman, Larry, et al.. (2015). Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial. Contraception. 91(6). 495–502. 12 indexed citations
4.
Kroll, Robin, et al.. (2014). A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation. The European Journal of Contraception & Reproductive Health Care. 20(4). 249–258. 11 indexed citations
5.
Seidman, Larry, et al.. (2014). Return to Ovulatory Capacity With Three Combined Oral Contraceptive Regimens. Obstetrics and Gynecology. 123(Supplement 1). 110S–111S. 3 indexed citations
6.
Gittelman, Marc, et al.. (2013). A Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Oxybutynin Vaginal Ring for Alleviation of Overactive Bladder Symptoms in Women. The Journal of Urology. 191(4). 1014–1021. 19 indexed citations
7.
8.
Archer, David F., Larry Seidman, Ginger D. Constantine, James H. Pickar, & Sophie Olivier. (2008). A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. American Journal of Obstetrics and Gynecology. 200(2). 172.e1–172.e10. 65 indexed citations
9.
Martin, Vincent T., Roger Cady, Alexander Mauskop, et al.. (2007). Efficacy of Rizatriptan for Menstrual Migraine in an Early Intervention Model: A Prospective Subgroup Analysis of the Rizatriptan TAME (Treat A Migraine Early) Studies. Headache The Journal of Head and Face Pain. 48(2). 226–235. 35 indexed citations
10.
Martin, Vincent T., et al.. (2006). Efficacy of Rizatriptan for Menstrual Migraine in the Treat A Migraine Early (TAME) Studies. Obstetrics and Gynecology. 107(Supplement). 7S–7S. 1 indexed citations
11.
Emkey, Ronald, William Koltun, Kathleen Beusterien, et al.. (2005). Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO). Current Medical Research and Opinion. 21(12). 1895–1903. 127 indexed citations
12.
13.
14.
Siami, Paul, Larry Seidman, & Daniel Lama. (2002). A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: The speed of onset of therapeutic assessment trial (STAT). Clinical Therapeutics. 24(4). 616–628. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sukanya Chaikittisilpa Breakdown of academic impact, for papers by Andrea Delbarba Breakdown of academic impact, for papers by Joel Lippman Breakdown of academic impact, for papers by George Kaparos Breakdown of academic impact, for papers by Sowmya Krishnan Breakdown of academic impact, for papers by Suat Hayri Küçük Breakdown of academic impact, for papers by Mervat M. El-Eshmawy Breakdown of academic impact, for papers by T. B. Paul Geurts Breakdown of academic impact, for papers by Yogesh Saxena Breakdown of academic impact, for papers by Jens Ulrich Hanisch
Rankless by CCL
2026